check quantity

Quan-T-RT™ [3H] - Reverse Transcriptase

Quan-T-RT™ contains the following components: Annealed primer/template bound to streptavidin-coated SPA beads, assay buffer, stop solution, [3H]TTP (3.7 MBq, 100 µCi) and instructions for use.

Part Number
List Price
Your Price
1152.00 USD
Buy Now

Please enter valid quantity

Please log in to add favorites.



The Quan-T-RT assay system has been optimized for the detection of reverse transcriptase in tissue culture supernatants. The Quan-T-RT™ kit is a reverse transcriptase enzyme assay which makes use of the scintillation proximity assay (SPA) principle. In an aqueous environment, relatively weak β-emitters, notably [3H] and [125I] (Auger electrons), need to be close to scintillant molecules in order to produce light, otherwise the energy is dissipated and lost in the solvent. PerkinElmer has used this concept to develop a range of homogeneous assays by coupling specific molecules on to fluomicrospheres (beads containing scintillant). The Quan-T-RT assay uses a DNA/RNA primer/template, bound to SPA beads via a biotin/streptavidin linkage. No use of liquid scintillant is required —the scintillant is incorporated chemically within the microsphere —and no washing steps are required to eliminate unincorporated radionucleotide from the assay, reducing both the time required for the assay and the potential risks to workers in handling viral samples.

The primer DNA, containing biotin at its 5’ end, is a 16mer oligo(T) which has been annealed to a poly(rA) template, approximately 300 bases in length. The primer/template is bound to a streptavidin-coated SPA bead. Incorporation of [3H]TTP and TTP by reverse transcription, results in extension of the primer. The incorporated tritiated nucleotides are able to stimulate the scintillant and produce a signal. Unincorporated, tritiated nucleotides, free in solution, are essentially unable to stimulate the scintillant and therefore produce no signal. Recombinant HIV-reverse transcriptase (rHIV-RT) can be used as a positive control or for creating a standard curve.


Detection Method Radiometric
Product Brand Name SPA Enzymatic Assays
Radioisotope H-3
Shipping Condition Ambient
Special Ordering Information This is a radioactive product - shipping address must have a license to receive radioactive materials.
Resources, Events & More
  • All


PerkinElmer Spa Reagents and Technologies

SPA reagents and CytoStar-T™ microplates let you see what you can’t see with any other technology, so your research becomes more productive. SPA from PerkinElmer. The advantages become even clearer at

PDF 640 KB


A HighThroughput Screening Assay for Human Serum Albumin Binding Using SPA

A screening assay has been developed for a lipase enzyme using the Scintillation Proximity Assay (SPA) technology and LEADseeker Homogeneous Imaging System. The assay uses a novel [3H] labelled biotinylated lipid substrate which was presented to the enzyme bound to the surface of SPA and LEADseeker beads.

Development of a Screening Assay for a Lipase Using Scintillation and Imaging Proximity Assay Technologies

Scintillation Proximity Assay (SPA) is an innovative approach to high throughput screening which allows the rapid and sensitive assay of a wide variety of biological processes in a homogeneous system. It is versatile, can be readily automated and assay costs are reduced as the requirement for filters, washing steps and scintillation reagents is eliminated.

Miniaturization of MC4 Receptor Binding Assay to 384 and 1536 Well Microplate Formats Utilizing SPA and Leadseeker Technologies

A homogeneous assay has been developed for HCV NS3 protease suitable for screening coloured natural product samples. Substrate concentration has been shown to effect IC50 values and hit rates by altering the proportion of inhibitors identified. The importance of optimisation of assay components such as bead concentration is shown.

New Bead Types for SPA Imaging Receptor Binding Assays

The throughput of samples for the direct measurement of cAMP in cell cultures can be significantly improved using LEADseeker Imaging technology. The standard curve generated in the one-stage assay and two-stage assay are comparable. This method has been validated with known pharmacological reagents.

PDF 399 KB